Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 44Pancreatic Neoplasms 39Rectal Neoplasms 20Colonic Neoplasms 19Stomach Neoplasms 18Neoplasm Metastasis 16Esophageal Neoplasms 13Cholangiocarcinoma 13Barrett Esophagus 11Carcinoma, Hepatocellular 10Ovarian Neoplasms 9Breast Neoplasms 9Adenocarcinoma Of Esophagus 9Melanoma 8Anus Neoplasms 8Neoplasms 7Sarcoma 6Lung Neoplasms 6Liver Neoplasms 6Glioma 6Gastroesophageal Reflux 6Gallbladder Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Hepatoblastoma 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenomatous Polyposis Coli 5Wilms Tumor 4

Interventions

Gemcitabine 6Cisplatin 6Capecitabine 6Liver Transplantation 4Fluorouracil 4Specimen Handling 3Radiosurgery 3Oxaliplatin 3Magnetic Resonance Spectroscopy 3toripalimab 2dehydroftorafur 2Self Expandable Metallic Stents 2Platinum 2Leucovorin 2Biopsy 23-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 21,2-diaminocyclohexaneplatinum II citrate 2trisacryl gelatin microspheres 1tremelimumab 1trametinib 1tislelizumab 1temoporfin 1sacituzumab govitecan 1ricolinostat 1pembrolizumab 1lenvatinib 1gemcitabine-oxaliplatin regimen 1fludarabine 1durvalumab 1binimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Klatskin Tumor × Biopsy × Gastrointestinal × Clear all
NCT05564403 2026-05-13

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
66 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06178588 2026-02-24

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

University of Kansas Medical Center

Phase 2 Active not recruiting
15 enrolled
Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡